Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kometer

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nature Reviews. Neuroscience|August 19, 2010
The neurobiology of psychedelic drugs: implications for the treatment of mood disordersFranz X Vollenweider, Michael Kometer
Current Topics in Behavioral Neurosciences|December 1, 2016
Serotonergic Hallucinogen-Induced Visual Perceptual AlterationsMichael Kometer, Franz X Vollenweider
Neuroimage|April 10, 2019
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effectsLukasz Smigielski, Milan Scheidegger, Michael Kometer, et al.
Psychopharmacology|August 2, 2015
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillationsMichael Kometer, Thomas Pokorny, Erich Seifritz, et al.
Psychopharmacology|July 28, 2012
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressionsAndré Schmidt, Michael Kometer, Rosilla Bachmann, et al.
Journal of Psychopharmacology (Oxford, England)|September 22, 2010
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studiesErich Studerus, Michael Kometer, Felix Hasler, et al.
Plos One|February 25, 2012
Prediction of psilocybin response in healthy volunteersErich Studerus, Alex Gamma, Michael Kometer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinationsMichael Kometer, André Schmidt, Lutz Jäncke, et al.
Plos One|October 11, 2012
Crowding deficits in the visual periphery of schizophrenia patientsRainer Kraehenmann, Franz X Vollenweider, Erich Seifritz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 30, 2011
Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteersBoris B Quednow, Michael Kometer, Mark A Geyer, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nature Reviews. Neuroscience|August 19, 2010
The neurobiology of psychedelic drugs: implications for the treatment of mood disordersFranz X Vollenweider, Michael Kometer
Current Topics in Behavioral Neurosciences|December 1, 2016
Serotonergic Hallucinogen-Induced Visual Perceptual AlterationsMichael Kometer, Franz X Vollenweider
Neuroimage|April 10, 2019
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effectsLukasz Smigielski, Milan Scheidegger, Michael Kometer, et al.
Psychopharmacology|August 2, 2015
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillationsMichael Kometer, Thomas Pokorny, Erich Seifritz, et al.
Psychopharmacology|July 28, 2012
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressionsAndré Schmidt, Michael Kometer, Rosilla Bachmann, et al.
Journal of Psychopharmacology (Oxford, England)|September 22, 2010
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studiesErich Studerus, Michael Kometer, Felix Hasler, et al.
Plos One|February 25, 2012
Prediction of psilocybin response in healthy volunteersErich Studerus, Alex Gamma, Michael Kometer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 21, 2013
Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinationsMichael Kometer, André Schmidt, Lutz Jäncke, et al.
Plos One|October 11, 2012
Crowding deficits in the visual periphery of schizophrenia patientsRainer Kraehenmann, Franz X Vollenweider, Erich Seifritz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 30, 2011
Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteersBoris B Quednow, Michael Kometer, Mark A Geyer, et al.
Pageof 4